cirpublications.com-yxBb-1790880684-f634136224 1790880684 Clinical Intelligence Research Press info@cirpublications.com Clinical Intelligence Research Press Journal of Artificial Intelligence for Healthcare Systems J. Artif. Intell. Healthc. Syst. 3149-8981 2025 4 2 Nikolai Ivanov Sergey Volkov Elena Morozova 2025 10.68159/f634136224 https://cirpublications.com/pub/journal/1/article/f634136224 Sundararajan M, Taly A, Yan Q. Axiomatic attribution for deep networks. Proc Mach Learn Res (PMLR). 2017;70:3319–28. Katzman JL, Shaham U, Cloninger A, Bates J, Jiang T, Kluger Y. DeepSurv: personalized treatment recommender system using a Cox proportional hazards deep neural network. BMC Med Res Methodol. 2018;18(1):24. Lee C, Zame W, Yoon J, Van der Schaar M. DeepHit: a deep learning approach to survival analysis with competing risks. Proc AAAI Conf Artif Intell. 2018;32(1). Nagpal C, Li X, Dubrawski A. Deep survival machines: fully parametric survival regression and representation learning for censored data with competing risks. IEEE J Biomed Health Inform. 2021;25(8):3163–75. Yao J, Zhu X, Jonnagaddala J, Hawkins N, Huang J. Whole slide images-based cancer survival prediction using attention-guided deep multiple instance learning networks. Med Image Anal. 2020;65:101789. Wang Z, Gao Q, Yi X, Zhang X, Zhang Y, et al. Survformer: an interpretable pattern-perceptive survival transformer for cancer survival prediction from histopathology whole slide images. Comput Methods Programs Biomed. 2023;241:107733. Hao J, Kim Y, Mallavarapu T, Oh JH, Kang M. Interpretable deep neural network for cancer survival analysis by integrating genomic and clinical data. BMC Med Genomics. 2019;12(Suppl 10):189. Langbein SH, Krzyziński M, Spytek M, Baniecki H, Biecek P, et al. Interpretable machine learning for survival analysis. Biom J. 2025;67(6):e70089. Mohamed YA, Khoo BE, Asaari MS, Aziz ME, Ghazali FR. Decoding the black box: explainable AI (XAI) for cancer diagnosis, prognosis, and treatment planning—a state-of-the-art systematic review. Int J Med Inform. 2025;193:105689. Núñez JJ, Leung B, Ho C, Bates AT, Ng RT. Predicting the survival of patients with cancer from their initial oncology consultation document using natural language processing. JAMA Netw Open. 2023;6(2):e230813. Dai X, Park JH, Yoo S, D'Imperio N, McMahon BH, Rentsch CT, et al. Survival analysis of localized prostate cancer with deep learning. Sci Rep. 2022;12(1):17821. 10.1038/s41598-022-22118-y Lee C, Light A, Saveliev ES, Van der Schaar M, Gnanapragasam VJ. Developing machine learning algorithms for dynamic estimation of progression during active surveillance for prostate cancer. NPJ Digit Med. 2022;5:110. Lee HW, Kim E, Na I, Kim CK, Seo SI, Park H. Novel multiparametric MRI-based deep learning and clinical parameter integration for prediction of long-term biochemical recurrence-free survival in prostate cancer after radical prostatectomy. Cancers. 2023;15(13):3416. Hu C, Qiao X, Huang R, Hu C, Bao J, Wang X. Development and validation of a multimodality model based on whole-slide imaging and biparametric MRI for predicting postoperative biochemical recurrence in prostate cancer. Radiol Imaging Cancer. 2024;6(3):e230143. Ferguson T, Ravani P, Sood MM, Clarke A, Komenda P, Rigatto C, et al. Development and External Validation of a Machine Learning Model for Progression of CKD. Kidney Int Rep. 2022;7(8):1772-81. 10.1016/j.ekir.2022.05.004 Al Hussein Al Awamlh B, Wallis CJ, Penson DF, Huang LC, Zhao Z, et al. Functional outcomes after localized prostate cancer treatment. JAMA. 2024;331(4):302–17. Pan H, Wang J, Shi W, Xu Z, Zhu E. Quantified treatment effect at the individual level is more indicative for personalized radical prostatectomy recommendation: implications for prostate cancer treatment using deep learning. J Cancer Res Clin Oncol. 2024;150(2):67. Wong NC, Lam C, Patterson L, Shayegan B. Use of machine learning to predict early biochemical recurrence after robot-assisted prostatectomy. BJU Int. 2019;123(1):51–7. Lee SJ, Yu SH, Kim Y, Kim JK, Hong JH, Kim CH, et al. Prediction system for prostate cancer recurrence using machine learning. Appl Sci. 2020;10(4):1333. Park J, Rho MJ, Moon HW, Kim J, Lee C, Kim D, et al. Dr. Answer AI for Prostate Cancer: Predicting Biochemical Recurrence Following Radical Prostatectomy. Technol Cancer Res Treat. 2021;20:15330338211024660. 10.1177/15330338211024660 Huang W, Randhawa R, Jain P, Hubbard S, Eickhoff J, Kummar S, et al. A Novel Artificial Intelligence-Powered Method for Prediction of Early Recurrence of Prostate Cancer After Prostatectomy and Cancer Drivers. JCO Clin Cancer Inform. 2022;6:e2100131. 10.1200/CCI.21.00131 Ekşi M, Evren İ, Akkaş F, Arıkan Y, Özdemir O, Özlü DN, et al, Taşçı AI. Machine learning algorithms can more efficiently predict biochemical recurrence after robot-assisted radical prostatectomy. Prostate. 2021;81(12):913-20. 10.1002/pros.24188 Bergero MA, Martínez P, Modina P, Hosman R, Villamil W, Gudiño R, et al. Artificial intelligence model for predicting early biochemical recurrence of prostate cancer after robotic-assisted radical prostatectomy. Sci Rep. 2025;15(1):30822. 10.1038/s41598-025-16362-1 Parker CC, Clarke NW, Cook AD, Kynaston HG, Petersen PM, Catton C, et al. Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial. Lancet. 2020;396(10260):1413-21. 10.1016/S0140-6736(20)31553-1 Van Den Eeden SK, Lu R, Zhang N, Quesenberry CP Jr, Shan J, et al. A biopsy-based 17-gene genomic prostate score as a predictor of metastases and prostate cancer death in surgically treated men with clinically localized disease. Eur Urol. 2018;73(1):129–38. Brooks MA, Thomas L, Magi-Galluzzi C, Li J, Crager MR, Lu R, et al. GPS Assay Association With Long-Term Cancer Outcomes: Twenty-Year Risk of Distant Metastasis and Prostate Cancer-Specific Mortality. JCO Precis Oncol. 2021;5:PO.20.00325. 10.1200/PO.20.00325 Nguyen PL, Haddad Z, Ross AE, Martin NE, Deheshi S, Lam LLC, et al. Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy Specimens. Eur Urol. 2017;72(5):845-52. 10.1016/j.eururo.2017.05.009 Van den Broeck T, Moris L, Gevaert T, Tosco L, Smeets E, Fishbane N, et al. Validation of the Decipher Test for Predicting Distant Metastatic Recurrence in Men with High-risk Nonmetastatic Prostate Cancer 10 Years After Surgery. Eur Urol Oncol. 2019;2(5):589-96. 10.1016/j.euo.2018.12.007 Jairath NK, Dal Pra A, Vince R Jr, Dess RT, Jackson WC, Tosoian JJ, et al. A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer. Eur Urol. 2021;79(3):374-83. 10.1016/j.eururo.2020.11.021